The Impact of Employee Wellness Programs
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03167658 |
Recruitment Status :
Completed
First Posted : May 30, 2017
Last Update Posted : September 9, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Health Behavior Disease, Chronic | Behavioral: Workplace wellness program | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 48664 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Each worksite (and all employees at that site) randomly assigned to Treatment or Control arm. |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | The Impact of Employee Wellness Programs |
Actual Study Start Date : | January 2015 |
Actual Primary Completion Date : | October 2018 |
Actual Study Completion Date : | June 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Treatment
Employees at treatment worksites will be given access to workplace wellness programming. Participation by employees will be voluntary, but all employees at treatment sites will be considered as part of the treatment group. Employees will also be invited to complete on-site biometric assessments and questionnaires. Data from secondary data sources (including employment records and health insurance claims) will be collected for employees at all BJ's worksites.
|
Behavioral: Workplace wellness program
Multi-prong workplace wellness program, with components such as nutrition counseling, fitness challenges, and stress management workshops, including supports and incentives. |
No Intervention: Primary Control
Employees at primary control worksites will be invited to complete on-site biometric assessments and questionnaires, but will not have access to the workplace wellness programming. Data from secondary data sources (including employment records and health insurance claims) will be collected for employees at all BJ's worksites.
|
|
No Intervention: Secondary Control
Employees at secondary control worksites will not participate in in-person screenings or questionnaires, and will not have access to workplace wellness programming. Data from secondary data sources (including employment records and health insurance claims) will be collected for employees at all BJ's worksites.
|
- Physical activity [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Regular exercise, number of hours sitting per day, and actively managing weight, as indicated in responses to survey questions
- Obesity [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Body Mass Index>=30, calculated from measured height and weight
- Absenteeism [ Time Frame: Administrative records from 3 years spanning intervention ]Number of sick or personal days as a share of total days employed, from employment records
- Health care spending [ Time Frame: Administrative records from 3 years spanning intervention ]Dollars spent on health care for employees covered by employer-sponsored insurance, from claims records
- Blood pressure [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Systolic blood pressure, measured
- Depression [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Unmanaged depression, as indicated in responses to survey questions
- Tenure [ Time Frame: Administrative records from 3 years spanning intervention ]Duration of employment in days, from employment records
- Job performance [ Time Frame: Administrative records from 3 years spanning intervention ]Numerical performance rating from annual review, from employment records
- Health care spending (i.e. dollars spent) [ Time Frame: Administrative records from 3 years spanning intervention ]Dollars spent on health care and prescription drugs for employees covered by employer-sponsored insurance, decomposed into spending on inpatient, outpatient, emergency department, and prescription drugs, from claims records
- Health care utilization (i.e. number of doctor visits, hospitalizations, or medications) [ Time Frame: Administrative records from 3 years spanning intervention ]Health care encounters and prescription drugs for employees covered by employer-sponsored insurance, decomposed into inpatient, outpatient, emergency department, and prescription drugs, from claims records
- Nutrition management [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Affirmative engagement in active efforts to improve nutrition, as indicated in responses to survey questions
- Stress management [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Unmanaged stress and stress at work, as indicated in responses to survey questions
- Screenings and exams [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Percent of recommended tests received, as indicated in responses to survey questions
- Tobacco use [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Smoking, as indicated in responses to survey questions
- Health and wellbeing [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Short form 8 (SF-8) physical and mental summary scores, as indicated in responses to survey questions. Each question of the SF-8 uses a 5- or 6-point Likert scale. Its standardized scoring system combines responses into a score that can be interpreted as a continuous variable (analogous to a 0-100 scale), with higher scores denoting better self-reported health.
- Blood glucose [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Blood glucose, measured
- Cholesterol [ Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention ]Total cholesterol and high-density lipoprotein (HDL), measured
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Employed in one of BJ's clubs during the period of the intervention
Exclusion Criteria:
- Not employed in one of BJ's clubs during the period of the intervention
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03167658
Principal Investigator: | Zirui Song, MD, PhD | Harvard Medical School (HMS and HSDM) |
Documents provided by Zirui Song, Harvard Medical School (HMS and HSDM):
Responsible Party: | Zirui Song, Assistant Professor of Health Care Policy and Medicine, Harvard Medical School (HMS and HSDM) |
ClinicalTrials.gov Identifier: | NCT03167658 |
Other Study ID Numbers: |
Wellness 14-3141 R01AG050329 ( U.S. NIH Grant/Contract ) P30AG012810 ( U.S. NIH Grant/Contract ) 72611 ( Other Grant/Funding Number: Robert Wood Johnson Foundation ) AEARCTR-0000586 ( Registry Identifier: American Economic Association Trial Registry ) |
First Posted: | May 30, 2017 Key Record Dates |
Last Update Posted: | September 9, 2021 |
Last Verified: | September 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Wellness Prevention |
Chronic Disease Disease Attributes Pathologic Processes |